NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 83 filers reported holding NOVAVAX INC in Q4 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | 0.0% | 291 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 291 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -33.3% | 291 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 291 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -66.7% | 291 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -94.9% | 291 | -92.7% | 0.00% | -100.0% |
| Q1 2022 | $294,000 | -45.9% | 3,996 | +5.3% | 0.00% | -33.3% |
| Q4 2021 | $543,000 | -31.6% | 3,796 | -0.9% | 0.00% | -40.0% |
| Q3 2021 | $794,000 | -29.6% | 3,830 | -27.9% | 0.01% | -37.5% |
| Q2 2021 | $1,128,000 | +4804.3% | 5,311 | +4115.1% | 0.01% | – |
| Q1 2021 | $23,000 | +76.9% | 126 | +5.0% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 120 | -18.9% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 148 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |